2025 ICD-10-CM code M33.03
(Active) Effective Date: N/A Revision Date: N/A Deletion Date: N/A Musculoskeletal and Connective Tissue Diseases - Systemic connective tissue disorders Chapter 13: Diseases of the musculoskeletal system and connective tissue Feed
Juvenile dermatomyositis without myopathy is a systemic inflammatory condition affecting blood vessels and skin in children 18 and under, without muscle weakness or elevated muscle enzymes.
Medical necessity for the diagnosis and treatment of juvenile dermatomyositis without myopathy is established by the presence of characteristic clinical features, including skin manifestations, and confirmation through laboratory tests and skin biopsy.The severity of the disease and potential complications justify the use of corticosteroids and immunosuppressants.Continued monitoring and adjustment of the treatment plan are necessary based on the patient’s response to therapy and the presence of any complications.
Diagnosis and management of juvenile dermatomyositis without myopathy involves a comprehensive approach including patient history, physical examination, laboratory testing (blood tests, muscle enzyme levels, ESR, ANA, specific antibody assays), imaging (MRI), skin biopsy, and initiation and monitoring of treatment with corticosteroids and immunosuppressants.Collaboration with specialists like dermatologists, rheumatologists, and potentially other specialists may be necessary depending on the complexity of the case and presence of other organ involvement.
- Chapter 13: Diseases of the musculoskeletal system and connective tissue
- M30-M36 (Systemic connective tissue disorders)
In simple words: Juvenile dermatomyositis without myopathy is a skin and blood vessel condition affecting children.It causes a rash, sores, and sometimes calcium deposits under the skin, but without muscle problems. Doctors use tests like blood work and skin biopsies for diagnosis, and treatment involves anti-inflammatory and immune-suppressing medicines.
Juvenile dermatomyositis without myopathy is a systemic inflammatory condition primarily affecting the blood vessels and skin in children aged 18 years and younger.It's characterized by skin manifestations such as a rash (often on the eyelids, elbows, knees, knuckles, fingers, and toes), skin ulcerations, and subcutaneous calcium deposits.Unlike other forms of dermatomyositis, this specific subtype does not present with muscle weakness or elevated muscle enzymes. The condition is diagnosed based on the patient's history, physical examination findings, imaging studies (such as MRI), blood tests (including erythrocyte sedimentation rate, antinuclear antibodies, antigen assays, and specific antibody assays to assess for elevated muscle enzymes), and skin biopsies.Treatment commonly involves corticosteroids (like prednisone) to manage inflammation, along with immunosuppressive medications.
Example 1: A 7-year-old presents with a characteristic heliotrope rash on the eyelids and Gottron's papules on the knuckles.Laboratory results show elevated inflammatory markers but normal muscle enzyme levels.A skin biopsy confirms the diagnosis of juvenile dermatomyositis without myopathy. Treatment is initiated with low-dose corticosteroids and close monitoring., A 12-year-old girl with a history of recurrent skin rashes and subcutaneous calcifications undergoes extensive testing, including MRI and muscle biopsies. Muscle enzyme levels are within normal limits, ruling out myopathy. The diagnosis of juvenile dermatomyositis without myopathy is confirmed, and treatment with immunosuppressants is initiated., A 15-year-old boy presents with a chronic rash, primarily affecting the elbows and knees. He reports no muscle weakness or fatigue.Blood tests show elevated inflammatory markers, while muscle enzyme levels are normal.Following a skin biopsy confirming the diagnosis of juvenile dermatomyositis without myopathy, treatment is initiated with corticosteroids and close monitoring of skin manifestations and potential side effects of treatment.
Complete patient history, including onset, duration, and progression of symptoms; thorough physical examination documenting skin lesions (heliotrope rash, Gottron's papules, etc.); laboratory results including complete blood count, inflammatory markers (ESR, CRP), muscle enzyme levels (CK, aldolase, AST, ALT), ANA, and specific antibody assays; imaging studies (MRI if indicated); results of skin biopsies with histopathological examination; documentation of treatment plan, including medications (corticosteroids, immunosuppressants), dosage, response to therapy, and any adverse effects; and progress notes detailing the patient's response to treatment and any relevant complications.
** This code specifically applies to juvenile dermatomyositis cases without the presence of myopathy.Accurate documentation is crucial to differentiate this from other forms of dermatomyositis and polymyositis.Close monitoring for potential complications and appropriate adjustments in the treatment plan are essential.
- Payment Status: Active
- Specialties:Rheumatology, Pediatric Rheumatology, Dermatology
- Place of Service:Office, Hospital Inpatient, Hospital Outpatient